Headquartered in Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional full-service CRO. With the increasing pace of globalization in drug development, Novotech’s expertise in the vibrant and fast growing Asian region has been instrumental in the success of hundreds of phase I-IV clinical trials from Australia to India. Headquartered in Sydney, with operations in New Zealand, China, Hong Kong, India, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand, Novotech’s service offering has come to be recognized for its quality both by our clients, as well as industry analyst groups.
Phone: 86, 21, 5172, 7381
Fax: 86, 21, 6091, 1461
Web: https://novotech-cro.com
Add：6 F, The 21st Century Building,No. 210, Century Avenue,Pudong New District Shanghai, 200120
Unit 1302B-04, 13/F,Fourseas Building,,208-212 Nathan Road, Kowloon, Hong Kong
想要下载更多资料，请您添加微信了解详情！
微信号：csco2022
公众号：康安医药咨询
